top of page

See if You Qualify

Eligibility

  • Documented diagnosis of Prader-Willi Syndrome (PWS)

  • Age 13 years old or older

  • Primary caregiver that can commit to the trial requirements for 12 weeks

Study Details

  • Eligible participants will either receive study drug or placebo (no active study drug ingredients).

  • Study drug will be taken orally twice daily for 12 weeks

  • Approximately 4 in-person clinic visits and 3 telehealth visits are required

  • Travel expenses and lodging (if required) for the participant and a primary caregiver will be covered 

  • No fasting required

  • All participants who complete the HERO study will have the option to participate in a follow up study where everyone will receive active study drug. 

Study Locations

  • Find the clinical site nearest you

bottom of page